Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Antibiot Khimioter ; 59(1-2): 20-3, 2014.
Article in Russian | MEDLINE | ID: mdl-25051712

ABSTRACT

Nineteen patients with bronchopulmonary infection and myasthenia gravis were enrolled in the study. The microbiological analysis of the specimens of phlegm and bronchial secretion revealed both grampositive and gramnegative bacteria. All the isolates were susceptible to the antibiotic used (cefoperazone/sulbactam). Intravenous immunoglobulins (IvIgs) were used to increase the treatment efficacy, to opsonize the infection foci and to decrease the hospitalization terms. The antibiotic therapy and simultaneous use of intravenous immunoglobulins provided higher clinical efficacy in 16 out of 19 patients (84.2%).


Subject(s)
Anti-Bacterial Agents/therapeutic use , Bronchopneumonia/drug therapy , Cefoperazone/therapeutic use , Immunoglobulins, Intravenous/therapeutic use , Myasthenia Gravis/drug therapy , Pneumonia, Bacterial/drug therapy , Sulbactam/therapeutic use , Adult , Aged , Aged, 80 and over , Bronchopneumonia/complications , Bronchopneumonia/immunology , Bronchopneumonia/microbiology , Drug Therapy, Combination , Female , Gram-Negative Bacteria/drug effects , Gram-Negative Bacteria/growth & development , Gram-Positive Bacteria/drug effects , Gram-Positive Bacteria/growth & development , Humans , Male , Middle Aged , Myasthenia Gravis/complications , Myasthenia Gravis/immunology , Myasthenia Gravis/microbiology , Pneumonia, Bacterial/complications , Pneumonia, Bacterial/immunology , Pneumonia, Bacterial/microbiology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...